Tag: Anticompetitive Harm
US: FTC loses Impax pay-for-delay case
A patent deal in which Endo Pharmaceuticals paid generic-drug maker Impax Laboratories to forgo launching a generic version of an opioid pain medication did...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.